Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.5720
-0.0307 (-5.09%)
At close: May 6, 2026, 4:00 PM EDT
0.6100
+0.0380 (6.64%)
After-hours: May 6, 2026, 7:28 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.91 million as of May 6, 2026. Its market cap has decreased by -68.63% in one year.
Market Cap
1.91M
Enterprise Value
-2.05M
1-Year Change
-68.63%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $1.91M, a decrease of -98.72%. That is a compound annual growth rate of -57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 2.01M | -66.56% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 2.95M |
| Biodexa Pharmaceuticals | 2.80M |
| Valion Bio | 2.80M |
| Oragenics | 2.73M |
| HCW Biologics | 2.69M |
| Virax Biolabs Group | 2.47M |
| Bone Biologics | 2.43M |
| Calidi Biotherapeutics | 2.32M |